期刊文献+

中国汉族、维吾尔族、哈萨克族CYP2D6基因型与表型比较

CYP2D6 genotypes and phenotypes in Chinese Han,Uygur and Kazakh populations
原文传递
导出
摘要 细胞色素P450 2D6(CYP2D6)是最具有基因多态性的药物代谢酶,在不同种族人群中呈遗传多态性并存在明显的种族差异,目前已发现70多个变异位点[1]。基因突变可以引起酶活性及数量的差异[2], This study is to compare the influence of CYP2D6 *3 and *4 genotypes and phenotypes on the metabolic activity of CYP2D6 in Chinese Han,Uygur and Kazakh ethnic groups.Allele specific amplification(ASA) was used to determine the CYP2D6*3 and CYP2D6*4 genotypes.Phenotypes of CYP2D6 in all subjects were determined using dextromethorphan as probe drug by HPLC methods.Among the 132 Han subjects,one subject(0.76%) exhibited the *1/*3 combination,and one(0.76%) exhibited the *1/*4.Among the 136 Uygur subjects,4 subjects(2.94%) showed the *1/*3 combination,12(8.82%) showed *1/*4,4(2.94%) showed *4/*4,and one(0.74%) showed *3/*4.Among the 116 Kazakh subjects,2(1.72%) exhibited the *1/*3 combination,7(6.03%) exhibited *1/*4,and one(0.86%) showed *4/*4.This research revealed significant differences in the occurrence frequencies of the CYP2D6 genotype between Han and Uygur ethnic groups,as well as between Uygur and Kazakh populations.However,no difference was found between Han and Kazakh populations.In addition,the prevalence of PMs of the Uygur is comparable to that of the Caucasians.However,the molecular mechanism underlying the poor metabolism is different in these two populations.
出处 《药学学报》 CAS CSCD 北大核心 2011年第2期238-242,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(39960080)
关键词 汉族 维吾尔族 哈萨克族 CYP2D6 右美沙芬 基因型 表型 Han Uygur Kazakh CYP2D6 dextromethorphan genotype phenotype
  • 相关文献

参考文献4

二级参考文献49

  • 1赵桐茂,张工梁,袁义达,杜若甫.用HLA基因频率计算人群间的遗传距离[J].人类学学报,1984,3(2):165-170. 被引量:10
  • 2艾琼华,肖辉,赵建新,许煜和,赛福鼎.维吾尔族的体质特征研究[J].人类学学报,1993,12(4):357-365. 被引量:109
  • 3刘营,楼雅卿,L.Bertilsson,F.Sjoqvist.我国汉族健康志愿者异喹胍羟化代谢缺陷频率及其药代动力学的研究[J].中国临床药理学杂志,1989,5(1):56-63. 被引量:9
  • 4俞民澍 等.中国汉族、维吾尔族、哈萨克族和回族群体线粒体DNA多态性的研究[J].中国科学:B辑,1988,1:60-70.
  • 5蔡卫民 陈冰 初晓.人尿中右美沙芬及其代谢物的高效液相色谱测定法[J].药学学报,1997,32:861-864.
  • 6袁义达 杜若甫.中国十七个民族间的遗传距离的初步研究[J].遗传学报,1983,10:398-405.
  • 7Bradford L D.CYP2D6 allele frequency in European Caucasians,Asians,Africans and their descendants[J].Pharmacogenomics,2002,3(2):229~243.
  • 8Zanger U M,Fischer J,Raimundo S,et al.Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6[J].Pharmacogenetics,2001,11(7):573~585.
  • 9Fukuda T,Nishida Y,Imaoka S,et al.The decreased in vivo clearance of CYP2D6 substrates by CYP2D6 * 10 might be caused not only by the low-expression but also by low affinity of CYP2D6[J].Arch Biochem Biophys,2000,380(2):303~308.
  • 10Yu A,Kneller B M,Rettie A E,et al.Expression,purification,biochemical characterization,and comparative function of human cytochrome P450 2D6.1,2D6.2,2D6.10 and 2D6.17 allelic isoformsIJ].J PharmacoL Exp Ther,2302,3(16(3):1291~1300.

共引文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部